Funds raising through the third-party allotment of common shares and the issuance of stock acquisition rights. Paid-in date: 2026\/10\/1 for approximately 1,359,300 shares, approximately 420.02 million yen raised; potential shares of 1,715,400 and maximum fundraising amount of about 532 million yen, total maximum around 952 million yen. Dilution: 25.06% for the common shares; no dilution for stock acquisition rights until exercised. Use of funds: for new business development, working capital, M&A, and capital partnership development.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4179","jir_company_name":"GeNexT","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-15","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4179-20260915-02.pdf","jir_short_summary":"Funds raising through the third-party allotment of common shares and the issuance of stock acquisition rights. Paid-in date: 2026\/10\/1 for approximately 1,359,300 shares, approximately 420.02 million yen raised; potential shares of 1,715,400 and maximum fundraising amount of about 532 million yen, total maximum around 952 million yen. Dilution: 25.06% for the common shares; no dilution for stock acquisition rights until exercised. Use of funds: for new business development, working capital, M&A, and capital partnership development.","jir_summary":"### Fundraising and Structure\nThis document provides a supplementary explanation for the fundraising through the issuance of new shares and the 8th series of stock acquisition rights via a third-party allotment, adopting a hybrid fundraising structure that combines common shares and stock acquisition rights. The new shares are planned to be paid in full immediately, with dilution limited to 25.06%. Meanwhile, the stock acquisition rights will be funded progressively upon exercise, ensuring additional fundraising capacity. The recipients of the allocation are multiple companies and associations, selected with consideration of each party\u2019s financial strength and business alignment.\n\n### Use of Funds and Business Policy\nFunds will be allocated to new business and service development (450 million yen), working capital (97 million yen), and funds for M&A and corporate partnerships (395 million yen). The company will continue to focus on three business domains\u2014software, hardware, and solutions\u2014while accelerating AI-driven business expansion through data utilization in collaboration with Discoveriez. The plan aims to maintain consistency with the mid-term management plan and accelerate capital partnerships and partner development.","jir_financial_highlights":"Issued shares: 1,359,300 shares (Unknown)\nFunds raised (this issue): 420,023,700 yen (Unknown)\nPotential shares (this stock acquisition rights): 1,715,400 shares (Unknown)\nMaximum fundraising amount: 952,380,936 yen (Unknown)\nDilution (this issue): 25.06% (Unknown)\nDilution (combined with stock acquisition rights): 56.68% (Unknown)","jir_category":"","jir_hashtags":"#GeNexT, #CapitalPolicy, #ThirdPartyAllotment, #StockAcquisitionRights, #UseOfFunds","jir_key_figures":"This issue issued shares: 1,359,300 shares\nThis stock acquisition rights potential shares: 1,715,400 shares\nMaximum fundraising amount: 952,380,936 yen","jir_meta_title":"GeNexT Supplement: Funds Raising through Issuance of New Shares and Stock Acquisition Rights | September 15, 2026","jir_meta_description":"GeNexT announces the issuance of new shares and the 8th series of stock acquisition rights through a third-party allotment. Details on paid-in date, dilution, allocation recipients, and use of funds for new business development, working capital, and partnership development to accelerate growth strategy.","jir_og_title":"GeNexT\u2019s Fundraising Combines New Shares and Stock Acquisition Rights","jir_og_description":"Overview of fundraising through issuance of new shares and stock acquisition rights, including dilution rate and use of funds. A key move linked to future growth strategy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61233,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"capital_policy","footnotes":""},"sector":[],"importance":[],"class_list":["post-114332","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n